ethanolamine has been researched along with Liver Neoplasms in 11 studies
Liver Neoplasms: Tumors or cancer of the LIVER.
Excerpt | Relevance | Reference |
---|---|---|
" Oral administration of NEN to mice significantly slowed growth of genetically induced liver tumors and patient-derived xenografts, whereas niclosamide did not, coinciding with the observed greater bioavailability of NEN compared with niclosamide." | 5.46 | Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. ( Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B, 2017) |
"Primary liver cancer is the fifth most common malignancy in men and the eighth in women worldwide." | 2.47 | In vivo magnetic resonance spectroscopy of liver tumors and metastases. ( Heerschap, A; Heijmen, L; ter Voert, EG; van Laarhoven, HW, 2011) |
" Oral administration of NEN to mice significantly slowed growth of genetically induced liver tumors and patient-derived xenografts, whereas niclosamide did not, coinciding with the observed greater bioavailability of NEN compared with niclosamide." | 1.46 | Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. ( Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (36.36) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alasadi, A | 1 |
Chen, M | 1 |
Swapna, GVT | 1 |
Tao, H | 1 |
Guo, J | 1 |
Collantes, J | 1 |
Fadhil, N | 1 |
Montelione, GT | 1 |
Jin, S | 1 |
Chen, B | 1 |
Wei, W | 1 |
Ma, L | 1 |
Yang, B | 1 |
Gill, RM | 1 |
Chua, MS | 1 |
Butte, AJ | 1 |
So, S | 1 |
ter Voert, EG | 1 |
Heijmen, L | 1 |
van Laarhoven, HW | 1 |
Heerschap, A | 1 |
Ye, G | 1 |
Zhu, B | 1 |
Yao, Z | 1 |
Yin, P | 1 |
Lu, X | 2 |
Kong, H | 1 |
Fan, F | 1 |
Jiao, B | 1 |
Xu, G | 1 |
LUCK, JM | 2 |
WILCOX, AA | 2 |
MATSUSHIMA, T | 1 |
INOUYE, M | 1 |
HIGASHI, K | 1 |
OIKAWA, A | 1 |
Badiani, K | 1 |
Arthur, G | 1 |
Dixon, RM | 1 |
Tian, M | 1 |
Shinohara, K | 1 |
Kong, ZL | 1 |
Nagamine, K | 1 |
Shiraishi, M | 1 |
Murakami, H | 1 |
Hefta, SA | 1 |
Hefta, LJ | 1 |
Lee, TD | 1 |
Paxton, RJ | 1 |
Shively, JE | 1 |
Burt, CT | 1 |
Koutcher, J | 1 |
Roberts, JT | 1 |
London, RE | 1 |
Chance, B | 1 |
1 review available for ethanolamine and Liver Neoplasms
Article | Year |
---|---|
In vivo magnetic resonance spectroscopy of liver tumors and metastases.
Topics: Carbon Isotopes; Choline; Ethanolamine; Humans; Liver Neoplasms; Magnetic Resonance Spectroscopy; Ne | 2011 |
10 other studies available for ethanolamine and Liver Neoplasms
Article | Year |
---|---|
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer.
Topics: Animals; Antinematodal Agents; Colonic Neoplasms; Ethanolamine; Humans; Liver Neoplasms; Mice; Niclo | 2018 |
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ce | 2017 |
Analysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometry.
Topics: Aconitic Acid; Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Energy Metabolism; Ethanol | 2012 |
Further studies on the factors that affect ethanolamine output.
Topics: Amino Alcohols; Animals; Carcinoma, Hepatocellular; Ethanolamine; Ethanolamines; Liver Neoplasms; Li | 1956 |
Further studies on the factors that affect ethanolamine output.
Topics: Amino Alcohols; Animals; Carcinoma, Hepatocellular; Ethanolamine; Ethanolamines; Liver Neoplasms; Li | 1956 |
Further studies on the factors that affect ethanolamine output.
Topics: Amino Alcohols; Animals; Carcinoma, Hepatocellular; Ethanolamine; Ethanolamines; Liver Neoplasms; Li | 1956 |
Further studies on the factors that affect ethanolamine output.
Topics: Amino Alcohols; Animals; Carcinoma, Hepatocellular; Ethanolamine; Ethanolamines; Liver Neoplasms; Li | 1956 |
SUBSTRATE OF THE ENZYMATIC REACTION CONCERNING LIBERATION OF ETHANOLAMINE IN RAT ASCITES HEPATOMA.
Topics: Amino Alcohols; Ascites; Carcinoma, Hepatocellular; Chromatography; Dialysis; Ethanolamine; Liver; L | 1963 |
3-Deazaadenosine and MDL29350 differentially affect the methylation of serine-and ethanolamine-derived phosphatidylethanolamine in Hep G2 cells.
Topics: Caproates; Carcinoma, Hepatocellular; Cell Line; Ethanolamine; Ethanolamines; Humans; Hypolipidemic | 1993 |
Phospholipid synthesis in the lymphomatous mouse liver studied by 31P nuclear magnetic resonance spectroscopy in vitro and by administration of 14C-radiolabelled compounds in vivo.
Topics: Animals; Body Weight; Carbon Radioisotopes; Choline; Ethanolamine; Ethanolamines; Liver Neoplasms; L | 1993 |
A novel human hepatoblastoma cell line (HuH-6KK) with rapid growth in serum-free medium without extracellular matrix.
Topics: Blood; Calcium Sulfate; Carcinoma, Hepatocellular; Cell Division; Culture Media; Ethanolamine; Ethan | 1990 |
Carcinoembryonic antigen is anchored to membranes by covalent attachment to a glycosylphosphatidylinositol moiety: identification of the ethanolamine linkage site.
Topics: Adenocarcinoma; Carcinoembryonic Antigen; Colonic Neoplasms; Ethanolamine; Ethanolamines; Glycosylph | 1988 |
Magnetic resonance spectroscopy of the musculoskeletal system.
Topics: Adolescent; Adult; Arm; Bone and Bones; Chemical Phenomena; Chemistry; Child; Electromagnetic Fields | 1986 |